cevac mass l lyophilisate for oculonasal suspension for chickens
ceva-phylaxia veterinary biologicals co. ltd - live attenuated infectious bronchitis disease virus, massachusetts type, strain b48 - lyophilisate for oculonasal suspension/use in drinking water - . - avian infectious bronchitis virus - chickens - immunological - live vaccine
ocuflox solution
abbvie corporation - ofloxacin - solution - 0.3% - ofloxacin 0.3% - antibacterials
oculac ear drops
wael pharmacy - povidone - ear drops
avishield ib h120, lyophilisate for oculonasal suspension/use in drinking water, for chickens
genera inc - avian infectious brochitis virus massachusetts serotype strain h-120 - lyophilisate for suspension for oculonasal or spray app - . - avian infectious bronchitis virus - chickens - immunological - live vaccine
nobilis ma5 + clone 30 lyophilisate for oculonasal suspension/use in drinking water for chickens
msd animal health uk limited - infectious bronchitis virus, newcastle disease virus - lyophilisate for oculonasal suspension/use in drinking water - live viral vaccine - chickens
clopixol drops
lundbeck israel ltd. - zuclopenthixol as dihydrochloride - solution - zuclopenthixol as dihydrochloride 20 mg/ml - zuclopenthixol - zuclopenthixol - acute schizophrenia and other acute psychoses.
oculoheel spigelia anthelmia and calcium sulfide toxicodendron pubescens leaf delphinium staphisagria seed apis mellifera sodium
heel inc - spigelia anthelmia (unii: wyt05213ge) (spigelia anthelmia - unii:wyt05213ge) - spigelia anthelmia 6 [hp_x] in 300 mg
avishield nd b1, lyophilisate for oculonasal suspension/use in drinking water for chickens.
genera inc - newcastle disease virus, live - lyophilisate for oculonasal suspension/use in drinking water - . - newcastle disease virus / paramyxovirus - chickens - immunological - live vaccine
haldol 2 mgml drops
j-c health care ltd - haloperidol - solution (oral) - haloperidol 2 mg/ml - haloperidol - haloperidol - haldol is indicatedin adult patients aged 18 years and above for:• treatment of schizophrenia and schizoaffective disorder.• acute treatment of delirium when non-pharmacological treatments have failed.• treatment of moderate to severe manic episodes associated with bipolar i disorder when other treatments cannot be used.• treatment of acute psychomotor agitation associated with psychotic disorder or manic episodes of bipolar i disorder.• treatment of persistent aggression and psychotic symptoms in patients with moderate to severe alzheimer’s dementia and vascular dementia when non-pharmacological treatments have failed and when there is a risk of harm to self or others.• treatment of tic disorders, including tourette’s syndrome, in patients with severe impairment after educational, psychological and other pharmacological treatments have failed.• treatment of mild to moderate chorea in huntington’s disease, when other medicinal products are ineffective or not tolerated.in paediatric patients for:• schizophrenia in adolescents aged 13 to 17 years when other pharmacological treatments have failed or are not tolerated.• persistent, severe aggression in children and adolescents aged 6 to 17 years with autism or pervasive developmental disorders, when other treatments have failed or are not tolerated. • tic disorders, including tourette’s syndrome, in children and adolescents aged 10 to 17 years with severe impairment after educational, psychological and other pharmacological treatments have failed.
neuleptil drops
searchlight pharma inc - periciazine - drops - 10mg - periciazine 10mg - phenothiazines